FDA Inspection 986244 — Mylan Laboratories Limited

Mylan Laboratories Limited — FEI 3005587313

The FDA completed an inspection of Mylan Laboratories Limited on September 14, 2016 in Sinnar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 14, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sinnar (India)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
126321 CFR 211.68(b)Computer control of master formula records
1591821 CFR 111.95(a)Records - production, process control: electronic
189021 CFR 211.165(e)Test methods
202721 CFR 211.192Investigations of discrepancies, failures
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up